Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10886443 | Drug Discovery Today | 2005 | 8 Pages |
Abstract
High-throughput target discovery requires robust disease models and the ability to rapidly survey the genome for function. In the post-genomics era, there has been a strong emphasis placed upon 'gene-to-function' approaches that take advantage of the large amount of gene sequence information now available. Here, we advocate a return to 'function-to-gene' approaches as a first step in target discovery (and validation), followed by hypothesis-driven research to validate new targets identified by their activity in cell-based disease models.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
P.David Jackson, John J. Harrington,